Overview
Xu-fei Huang practices in Beijing, China. Huang is rated as an Advanced expert by MediFind in the treatment of POEMS Syndrome. Their top areas of expertise are POEMS Syndrome, Primary Amyloidosis, Papilledema, and Monoclonal Gammopathy of Undetermined Significance (MGUS).
Their clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of POEMS Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- POEMS SyndromeHuang isAdvanced. Learn about POEMS Syndrome.
- Experienced
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- PapilledemaHuang isExperienced. Learn about Papilledema.
- Primary AmyloidosisHuang isExperienced. Learn about Primary Amyloidosis.